TransCode Therapeutics
NASDAQ: RNAZ
Healthcare
Biotechnology
Rank
#40188
Market Cap
8.34 M
Volume
1.79 M
Price
0.36
Change (%)
4.51%
Country or region
United States
United States
TransCode Therapeutics's latest marketcap:
8.34 M
As of May 13, 2025, TransCode Therapeutics's market capitalization has reached $8.34 M. According to our data, TransCode Therapeutics is the 40188th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 8.34 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -16,754,971 |
| Shares Out | 23.34 M |
| EPS (ttm) | -47.05 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 20, 2025 |
Market Cap Chart
Data Updated: May 13, 2025
TransCode Therapeutics's yearly market capitalization.
TransCode Therapeutics has seen its market value drop from $32.72 M to $8.34 M since 2021, representing a total decrease of 74.52% and an annual compound decline rate (CAGR) of 33.38%.
| Date | Market Cap | Change (%) |
|---|---|---|
| May 13, 2025 | $8.34 M | 240.02% |
| December 31, 2024 | $2.35 M | -43.27% |
| December 29, 2023 | $4.14 M | -52.59% |
| December 30, 2022 | $8.72 M | -73.34% |
| December 31, 2021 | $32.72 M |
Company Profile
Frequently Asked Questions
As of May 13, 2025, TransCode Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $8.34 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
TransCode Therapeutics global market capitalization ranking is approximately 40188 as of May 13, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2016 |
| IPO Date | July 9, 2021 |
| Employees | 7 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address |
